FXR: the key to benefits in bariatric surgery? (original) (raw)

Nature Medicine volume 20, pages 337–338 (2014)Cite this article

Subjects

Bariatric surgery reduces the weight of morbidly obese individuals and exerts beneficial effects on associated metabolic disorders such as type 2 diabetes. However, despite growing traction in this area of metabolic research, questions remain as to the mechanisms that lead to these benefits. New findings propose that the bile acid–activated nuclear receptor FXR mediates the metabolic improvement seen after one particular bariatric surgery approach and that this may involve alterations in the microbiome.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Figure 1: The bile acid enterohepatic cycle and its potential links to the positive effects of bariatric surgery.

References

  1. Yanovski, S.Z. & Yanovski, J.A. J. Am. Med. Assoc. 311, 74–86 (2014).
    Article CAS Google Scholar
  2. Schauer, P.R. et al. N. Engl. J. Med. 366, 1567–1576 (2012).
    Article CAS Google Scholar
  3. Karamanakos, S.N. et al. Ann. Surg. 247, 401–407 (2008).
    Article Google Scholar
  4. Ryan, K.K. et al. Nature, doi:10.1038/nature13135 (26 March 2014).
  5. Lefebvre, P. et al. Physiol. Rev. 89, 147–191 (2009).
    Article CAS Google Scholar
  6. Ridlon, J.M. et al. J. Lipid Res. 47, 241–259 (2006).
    Article CAS Google Scholar
  7. Patti, M.E. et al. Obesity (Silver Spring) 17, 1671–1677 (2009).
    Article CAS Google Scholar
  8. Kohli, R. et al. J. Clin. Endocrinol. Metab. 98, E708–E712 (2013).
    Article CAS Google Scholar
  9. Sinal, C.J. et al. Cell 102, 731–744 (2000).
    Article CAS Google Scholar
  10. Kok, T. et al. J. Biol. Chem. 278, 41930–41937 (2003).
    Article CAS Google Scholar
  11. Cariou, B. et al. J. Biol. Chem. 281, 11039–11049 (2006).
    Article CAS Google Scholar
  12. Zhang, Y. et al. Mol. Endocrinol. 26, 272–280 (2012).
    Article CAS Google Scholar
  13. Prawitt, J. et al. Diabetes 60, 1861–1871 (2011).
    Article CAS Google Scholar
  14. Cariou, B. et al. FEBS Lett. 581, 5191–5198 (2007).
    Article CAS Google Scholar
  15. Dewulf, E.M. et al. Gut 62, 1112–1121 (2013).
    Article CAS Google Scholar
  16. Li, F. et al. Nat. Commun. 4, 2384 (2013).
    Article Google Scholar

Download references

Author information

Authors and Affiliations

  1. Folkert Kuipers and Albert K. Groen are at the Departments of Pediatrics and Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.,
    Folkert Kuipers & Albert K. Groen

Authors

  1. Folkert Kuipers
    You can also search for this author inPubMed Google Scholar
  2. Albert K. Groen
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toFolkert Kuipers.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

About this article

Cite this article

Kuipers, F., Groen, A. FXR: the key to benefits in bariatric surgery?.Nat Med 20, 337–338 (2014). https://doi.org/10.1038/nm.3525

Download citation

This article is cited by